GPhA Rebrands Itself and Changes its Name to the Association for Accessible Medicines February 17, 2017 By Nicholas Hamm GPhA, the generic drug industry’s leading trade organization, adopted a new name: the Association for Accessible Medicines (AAM). The new name reflects the organization's mission “to make more medicines more accessible to more people who need them.” Health information technology in the community pharmacy Local HIE, regional EHR, interoperability all over the place -- get your pharmacy ready. They're practically here. Patient care at med sync improves outcomes, revenue August 10, 2016 By Howard Larkin And Medicare, Medicaid, and private insurers are increasingly willing to pay. Coming regs expand pharmacist role in LTC August 10, 2016 By Howard Larkin “Basically, everything we know will be gutted over the next three years.” Physician-pharmacist partnerships key to higher profits, future progress August 10, 2016 By Howard Larkin Once physicians see what you can do for them, they won't want to let you go. A lesson in prospective drug review: What is your job? What is the pharmacist’s duty? This case history may shed some light. An overview of FDA’s 503B outsourcing facility requirements FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health. FDA approves brivaracetam for use in partial onset seizure treatment Brivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.